Editorials |
From the Department of Anatomy and Cell Biology (G.B., D.J.) and Pharmacology (P.D-.J.), Faculty of Medicine, University of Sherbrooke, Quebec, Canada.
Correspondence to G. Bkaily, Department of Anatomy and Cell Biology, Faculty of Medicine, University of Sherbrooke, Quebec, Canada, J1H 5N4. E-mail Ghassan.Bkaily@Usherbrooke.ca
See related article, pages 870877
Key Words: caveolae eNOS NO calcium endothelial cells
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
Caveolae, cholesterol rich microdomain platforms localized mostly at the cytoplasmic membrane of endothelial cells as well as other cell types, are importantly involved in cell signaling and enzymatic activity.16 Caveolae also contain cationic amino acid transporter (CAT) which provide L-Arginine to the eNOS-Ca2+-Calmodulin complex toward the production of nitric oxide (NO).16
Caveolin-1, a major caveolae-localized protein, represses markedly eNOS-dependent NO production by interfering with NADPH-dependent electron flux.3 Alteration in caveolin abundance or its subcellular location leads to the control of NO production.5,6 Thus, it is clear, that the more the caveolin the less the NO, and inversely.3
The conventional paradigm supports the concept that eNOScaveolin-1 interaction promotes inhibition of NO production, whereas increased intracellular Ca2+ activates Ca2+-Calmodulin which in turn disrupts the eNOScaveolin-1 interaction and thus liberates the enzyme. This in turn promotes NO production.16
A new paradigm is now suggested by Miniatis and colleagues7, who elegantly demonstrated that NO production in pulmonary endothelial cells is significantly mediated by caveolae internalization and is independent of the increase of intracellular Ca2+.7 Furthermore, these authors clearly show that the albumin-binding protein gp60 is importantly involved in both caveolae internalization and consequently in the increase of the endothelial NOS dependent NO release.
In their study, Miniatis et al, adopted a strategy demonstrating, under specific experimental conditions, that the NO release following activation of eNOS activity by gp60 was Ca2+-independent.7 The fact that the intracellular loaded Ca2+ chelator BAPTA had no effect on NO production when compared with control supports
Related Article:
Circ. Res. 2006 99: 870-877.
This article has been cited by other articles:
![]() |
R. M. Touyz Regulation of Endothelial Nitric Oxide Synthase by Thrombin Hypertension, March 1, 2007; 49(3): 429 - 431. [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |